Clinical Trials
7
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)β’ Click on a phase to view related trials
MOTIV BTK Randomized Controlled Trial
- Conditions
- Critical Limb Ischemia
- First Posted Date
- 2022-06-06
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- REVA Medical, Inc.
- Target Recruit Count
- 292
- Registration Number
- NCT05406622
- Locations
- πΊπΈ
Adventist Health, Saint Helena, California, United States
πΊπΈUnityPoint Health Trinity Bettendorf Hospital, Bettendorf, Iowa, United States
πΊπΈCardiovascular Medicine PC, Davenport, Iowa, United States
FANTOM Post Market Clinical Trial
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2018-07-16
- Last Posted Date
- 2024-06-14
- Lead Sponsor
- REVA Medical, Inc.
- Target Recruit Count
- 1500
- Registration Number
- NCT03587922
- Locations
- π¦πΉ
Wilhelminenhospital, Wien, Austria
π©πͺJuedisches Krankenhaus Berlin, Berlin, Germany
π©πͺTechnische Universitat Dresden, Dresden, Germany
Safety & Performance Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2015-09-03
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- REVA Medical, Inc.
- Target Recruit Count
- 272
- Registration Number
- NCT02539966
- Locations
- π¦πΊ
The Prince Charles Hospital, Chermside, Australia
π¦πΊSt Vincent's Hospital Sydney, Darlinghurst, Australia
π¦πΊPrince of Wales Hospital (Eastern Heart), Randwick, Australia
Pilot Study of the Fantom Bioresorbable Scaffold (FANTOM I)
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2015-07-30
- Last Posted Date
- 2023-03-29
- Lead Sponsor
- REVA Medical, Inc.
- Target Recruit Count
- 7
- Registration Number
- NCT02512003
- Locations
- π§π·
Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil
π΅π±Pracownia Kardiologii Inwazyjnej I Katedry i Kliniki Kardiologii WUM, Warszawa, Poland
ReZolve2 Clinical Investigation
- Conditions
- Coronary Artery DiseaseCoronary Artery Stenosis
- First Posted Date
- 2013-05-03
- Last Posted Date
- 2023-03-29
- Lead Sponsor
- REVA Medical, Inc.
- Target Recruit Count
- 89
- Registration Number
- NCT01845311
- Locations
- π¦πΊ
St Vincent's Hospital, Sydney, Australia
π§π·Instituto Dante Pazzanese de Cariologia, Sao Paulo, Brazil
π©πͺCardioangiologisches Centrum Bethanien, Frankfurt, Germany
- Prev
- 1
- 2
- Next